 Ovid Therapeutics Inc NASDAQ:OVIDs share price was up 5.6 during mid-day trading on Tuesday after Citigroup raised their price target on the stock from 8.00 to 9.00. Citigroup currently has a buy rating on the stock. Ovid Therapeutics traded as high as 7.39 and last traded at 7.39, approximately 1,016,715 shares traded hands during trading. ... 